Stem cell transplant offers long-term hope for severe scleroderma patientsAn intensive stem cell transplant regimen achieved better survival as compared to cyclophosphamide treatment for patients with severe scleroderma, researchers report in the New England Journal of Medicine.
Scleroderma skin ulcersScleroderma skin ulcers are challenging to manage and can be approached with a variety of therapies and treatments.
Actemra gets breakthrough therapy designation for sclerodermaThe FDA has granted breakthrough therapy designation to tocilizumab (Actemra, Genentech) for the treatment of systemic sclerosis, a rare and potentially life-threatening disease with no FDA-approved therapy.
Scleroderma patients with pulmonary problems face higher mortality riskA new study strongly links pulmonary complications to survival rates among scleroderma patients.
Study: Cancer may trigger sclerodermaResults of a Johns Hopkins study suggest that cancer triggers the autoimmune disease scleroderma.
Joint committee updates criteria for sclerodermaUpdated classification criteria for scleroderma should allow for earlier identification and treatment of the autoimmune disease.
Antibodies’ role in scleroderma variant uncertainA recent study confirms the presence of certain antibodies in patients with morphea, but only in linear morphea is the presence associated with clinical indicators of severity.
Gene therapy may benefit patients with sclerodermaClinicians may one day be able to treat scleroderma more effectively, as researchers have uncovered how gene expression signatures can identify patients who respond well to particular therapies.